Price: $0.0100
$0.00
-8.257%
|
Day's High:
| $0.0107
| Week Perf:
| -4.76 %
|
Day's Low: |
$ 0.01 |
30 Day Perf: |
5.26 % |
Volume (M): |
2,525 |
52 Wk High: |
$ 0.08 |
Volume (M$): |
$ 25 |
52 Wk Avg: |
$0.02 |
Open: |
$0.01 |
52 Wk Low: |
$0.01 |
|
|
Market Capitalization (Millions $) |
4 |
Shares
Outstanding (Millions) |
367 |
Employees |
8 |
Revenues (TTM) (Millions $) |
3 |
Net Income (TTM) (Millions $) |
3 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
7 |
Livento Group Inc
We were incorporated in the State of Nevada on October 30, 2013 under the name
“Bling Marketing, Inc.” Until December 29, 2014, we were a wholesaler
of jewelry, principally earrings, rings and pendants (“BMI Business”).
We recognized a minimal amount of sales from operations prior to the three months
ended September 30, 2014.
NuGene was incorporated in California in December 2006 and formed and funded
by our founders, Ali Kharazmi and Mohammed Kharazmi, M.D. The initial focus
of the NuGene was to develop and market customized skin care products. As part
of that focus, NuGene sought to leverage the working relationships developed
by our founders with the plastic surgery community. NuGene directed significant
time and resources on developing anti-aging and scar treatment/reduction products.
In 2007 we continued to focus on age defying products utilizing peptide complexes
and nano-encapsulation for absorption into the skin. We introduced a limited
product line under the NuGene name, and co-branded the products with an affiliated
entity, Genetic Institute of Anti Aging, Inc. (“GIAA”), which is
also owned by our founders. We utilized the services of a Korean based contract
manufacturer to supply our products. This product line (the “GIAA Line”)
was based on the use of peptides and did not utilize stem cells. We had very
modest sales in 2007, with our sole customer being GIAA, a related party.
“Cosmeceuticals” refer to the combinations of cosmetics and pharmaceuticals
that may offer medicinal or drug-like benefits. The term is more of a marketing
term rather than a legal term, with the cosmetics industry having adopted the
term in the late 1990’s. The US Food and Drug Administration (the “FDA”)
does not recognize the term. While drugs are subject to a review and approval
process by the FDA, cosmetics and cosmeceuticals are not subject to the same
stringent regulatory regime and scrutiny. As such, if a product has drug properties,
it must be approved as a drug. However, cosmeceuticals are not subject to this
review and approval process.
Cosmeceuticals offer consumers cosmetic-like treatments with active ingredients,
which in our view give them pharmaceutical-like efficacy. Driven by aesthetic-consciousness,
according to the May 2014 RNCOS research publication entitled, “Global
Cosmeceuticals Market Outlook 2018” the global market for cosmeceutical
products has reached an estimated size of $35.1 billion in 2013. We believe
that this market benefits from the growing segment of a younger generation of
consumers as well as baby boomers who want to preserve their youthful looks.
In our view the U.S. cosmeceutical market will continue to be favorably influenced
by these growing segments of people who want beautiful and younger looking skin
while aging.
In our view, age-defying products represent (and will continue to represent)
a significant portion of the facial skincare market. In key markets, we believe
that the facial skincare market is positioned for significant growth with limited
downside risks from the overall condition of the economy. In order to make claims
that products can diminish the signs of aging, marketers are constantly looking
for new combinations of specialty ingredients. The category of skincare products
based on biotechnology such as human stem cell is in our view just beginning
to be developed, and therefore we expect that it has significant growth potential.
Our goal is to leverage our knowledge in human adult stem cell technology to
develop and commercialize advanced anti-aging skincare products for the retail
and professional channels. We intend to develop, manufacture, and market cosmetic
skin care and hair products to address this significant market opportunity.
Our business plan entails having our NuGene Line of products continue to be
sold domestically and internationally through professional channels, including
dermatologists, plastic surgeons, medical offices, and day and resort spas.
We also expect to directly market our product through television sales-dedicated
channels. We plan to promote brand awareness through advertising, our own sales
personnel, other marketing and public relations. We will also partially rely
upon the name recognition of Kathy Ireland secured under the License Agreement
discussed below. We propose to further expand our sales efforts through our
branded website (www.nugene.com) and additional online commerce channels.
Company Address: 17 State Street New York 10004 NY
Company Phone Number: 432-8241 Stock Exchange / Ticker: NUGN
NUGN is expected to report next financial results on March 30, 2024. |
|
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Mongodb Inc
Mongodb Inc, a leading Software and Programming company, recently reported a disappointing financial performance for the period ending January 31, 2024. With a significant decline in revenue and widening shortfall per share, it is crucial to analyze the potential impact of these setbacks on the company's future prospects. Revenue Decline and Shortfall: Mongodb Inc's financial report revealed a substantial decline in revenue, plummeting by -83.553% to $59.43 million compared to the same period the previous year. Moreover, the shortfall per share widened to $-3.47 from $-0.41 in the prior year's reporting period. These alarming figures depict the company's struggle to generate sufficient income and maintain profitability, particularly when compared to the sector's overall revenue gain.
|
Pagerduty Inc
PagerDuty Inc. (PD), a leader in digital operations management, recently announced its strong revenue growth of 355.951% year on year to $52.75 million in the fourth quarter of the 2024 earnings season. While this may seem impressive at first glance, a closer look reveals concerning trends that suggest the company is heading in the wrong direction. PD's revenue advancement in the fourth quarter of 2024 may correlate advantageously to its Software and Programming sector contemporaries, who experienced an overall 3.66% top-line advance in the same period. However, when compared to the preceding financial reporting period, PD's losses increased from $-0.16 per share, and revenue tumbled by a staggering -51.165% from $108.02 million.
|
Bigbear Ai Holdings Inc
BigBear.ai Holdings Inc, a renowned leader in AI-powered decision intelligence solutions, has recently made waves in the stock market with its groundbreaking acquisition. The company has successfully completed a merger with Pangiam Intermediate Holdings, LLC, which is set to establish BigBear.ai as a breakout leader in Vision AI for critical sectors such as national security, supply chain management, and digital identity. This strategic move is expected to revolutionize decision-making processes by providing unparalleled clarity and insights. BigBear.ai has been widely acknowledged for its expertise in delivering AI-powered solutions for national security. By joining forces with Pangiam, a company with vast knowledge in Vision AI for the global trade and travel industries, the merged entity is positioned to become an undisputed leader in addressing complex national security challenges. The impact of this union will be far-reaching and transformative, greatly enhancing threat detection, improving surveillance capabilities, and strengthening border control measures.
|
Porch Group Inc
Porch Group Inc. has certainly impressed investors with its stellar performance in the financial fourth quarter of 2023. With a remarkable increase in revenue by 70.422% to $114.61 million, the company has managed to significantly reduce its losses to just $-0.03 per share, compared to $-0.39 in the same period last year. This impressive feat has outshined its industry counterparts in the Software and Programming sector, which only saw a 3.66% increase in revenue during the same timeframe. It is evident that Porch Group Inc. is on the path to success, with a clear improvement in its financials compared to previous quarters. The company reported a net loss of $-2.486 million in the October to December 31, 2023 timeframe, a massive improvement from the $-37.995 million loss in the same period a year ago. Additionally, the company's accounts receivable have declined, which some analysts attribute to a slowdown in demand.
|
Asana Inc
Asana Inc, a leading work management platform, recently released its financial results for the fourth quarter and fiscal year ended January 31, 2024. While the company reported a decrease in revenue and net loss per share compared to the previous year, the overall performance beat expectations. This article delves into the impact of the results and why the future looks promising for Asana. Disastrous Revenue Performance: Despite experiencing a challenging November to January period, Asana's revenue decreased by only -55.982% to $66.13 million. Although this decline may seem concerning, it is important to note that the Software and Programming sector as a whole recorded a revenue rise in the fourth quarter of 2024. This suggests that the sector experienced similar challenges, and Asana fared better than its competitors.
|
Per Share |
Current |
Earnings (TTM) |
0.19 $ |
Revenues (TTM) |
0.01 $
|
Cash Flow (TTM) |
0 $ |
Cash |
0 $
|
Book Value |
0.12 $
|
Dividend (TTM) |
0 $ |
|
Per Share |
|
Earnings (TTM) |
0.19 $
|
Revenues (TTM) |
0.01 $ |
Cash Flow (TTM) |
0 $ |
Cash |
0 $
|
Book Value |
0.12 $ |
Dividend (TTM) |
0 $ |
|
|
|
|